Overview

Detailed Summary

Emami Limited is a leading FMCG company in India, specializing in personal care and healthcare products, with prominent brands like Navratna, BoroPlus, and Zandu in its portfolio.
In Q3FY26, Emami achieved strong performance with consolidated net sales of ₹1,147 crore, growing by 11%, driven by a robust 9% volume growth in its domestic market and 9% growth in international business.
The company showcased successful innovation and portfolio expansion, launching products such as Kesh King Gold and BoroPlus variants. This strategy aligned with their focus on premiumization and capturing evolving consumer needs.
Emami's omnichannel approach has been effective, with organized channels contributing 32% of revenues. The company's digital strategy is advancing, with digital spending accounting for 50% of media expenses, enabling targeted consumer engagement.
The company declared a dividend of ₹6 per share as the second interim dividend for FY26, illustrating Emami's confidence in its financial performance and commitment to rewarding shareholders.

Sector: FMCG
Industry: Personal Care - Indian - Large
Market Cap: 21,306 Cr
Volatility: Low Risk
P/E Ratio: 26.6
Industry P/E: 48.6
PEG Ratio: 2.6
P/B Ratio: 7.3
52W High: 655.40
52W Low: 470.00

Sales CAGR

1Y: 6.46%
3Y: 2.90%
5Y: 5.50%
10Y: 4.03%

Profit CAGR

1Y: 10.85%
3Y: 0.33%
5Y: 24.34%
10Y: 11.14%

ROE

TTM: 25.72%
3Y: 29.07%
5Y: 30.65%
10Y: 24.68%

ROCE

TTM: 27.90%
3Y: 31.08%
5Y: 31.46%
10Y: 27.24%

Technicals

‌

Forecasts

Unlock Premium Features

Analyst Target, Price, EPS and Revenue Projections

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
GILLETTE	8463.60	27,627 Cr	44.45	23.76	1.32	49.37	66.89	28.87
AWL	203.75	26,481 Cr	27.61	2.67	0.00	10.92	19.40	3.59
EMAMILTD	489.95	21,306 Cr	26.61	7.27	2.05	25.72	27.90	21.64
HATSUN	900.30	20,080 Cr	57.56	10.98	0.67	17.97	16.05	7.86
AVANTIFEED	1346.05	18,339 Cr	28.99	6.09	0.67	20.55	28.79	15.94
BIKAJI	636.35	15,856 Cr	63.89	10.58	0.16	14.21	16.12	10.88
LTFOODS	426.25	14,802 Cr	22.77	3.53	0.70	15.19	15.58	8.52

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	865	996	891	906	891	1,049	963	904	799	1,152
Expenses	631	681	680	690	640	711	744	690	620	768
Operating Profit	234	315	211	217	250	339	219	214	179	384
OPM %	27.02	31.60	23.67	23.90	28.12	32.27	22.79	23.69	22.36	33.36
Other Income	10	9.78	9.13	8.36	17	10	21	19	20	9.09
Interest	2.25	2.71	2.88	2.06	2.33	2.17	2.78	2.43	2.63	2.92
Depreciation	46	46	48	44	45	46	44	45	45	45
Profit Before Tax	196	276	169	178	220	301	194	187	150	345
Tax %	8.08	5.61	13.28	15.57	4.28	7.42	16.28	12.05	1.22	7.41
Net Profit	180	261	147	151	211	279	162	164	148	319
EPS in Rs	4.09	5.92	3.41	3.50	4.87	6.39	3.72	3.76	3.40	7.32

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	2,528	2,541	2,695	2,655	2,881	3,192	3,406	3,578	3,809	3,807
Expenses	1,729	1,811	1,967	1,964	1,997	2,240	2,543	2,629	2,784	2,784
Operating Profit	799	730	727	691	883	952	863	950	1,025	1,023
OPM %	31.60	28.72	26.99	26.01	30.66	29.84	25.33	26.54	26.91	26.87
Other Income	31	18	23	40	66	75	61	37	56	67
Interest	58	34	21	21	13	5.07	7.39	9.98	9.34	9.71
Depreciation	309	311	325	336	367	335	247	186	178	178
Profit Before Tax	424	393	403	374	569	688	670	791	894	902
Tax %	19.74	21.97	25.01	19.08	20.08	-21.61	6.29	8.43	10.19	9.52
Net Profit	340	306	303	302	455	837	627	724	803	816
EPS in Rs	9.20	7.03	6.95	6.94	10.41	19.17	14.63	16.57	18.48	18.20
Dividend Payout %	46.67	103.40	59.88	59.97	78.20	42.37	55.17	48.34	54.11	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	23	23	23	45	45	44	44	44	44	44
Reserves	1,589	1,732	1,991	2,031	1,778	1,718	2,032	2,259	2,403	2,651
Borrowings	671	173	326	110	210	101	282	91	94	90
Other Liabilities	409	676	461	636	644	656	699	717	739	749
Total Liabilities	2,692	2,603	2,801	2,822	2,678	2,520	3,057	3,110	3,280	3,534
Fixed Assets	1,918	1,940	1,746	1,625	1,405	1,079	1,290	1,192	1,062	933
CWIP	67	22	30	36	8.05	6.43	3.08	6.33	7.55	15
Investments	104	182	369	242	211	308	357	347	494	727
Other Assets	604	460	655	919	1,055	1,126	1,408	1,565	1,717	1,859
Total Assets	2,692	2,603	2,801	2,822	2,678	2,520	3,057	3,110	3,280	3,534

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	562	730	588	554	531	922	644	749	779	896
Cash from Investing Activity	-1,313	-306	-276	-26	-231	-224	-234	-122	-210	-345
Cash from Financing Activity	502	-496	-324	-428	-405	-688	-402	-608	-563	-500
Net Cash Flow	-249	-72	-12	100	-106	8.97	7.76	19	6.17	52

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	54.27%	54.52%	54.84%	54.84%	54.84%	54.84%	54.84%	54.84%	54.84%	54.84%	54.84%	54.84%
FIIs	11.01%	11.45%	11.91%	12.86%	13.46%	14.02%	14.38%	14.11%	12.11%	11.89%	10.93%	9.03%
DIIs	26.92%	26.23%	25.22%	23.95%	22.07%	21.61%	21.51%	21.70%	23.67%	24.06%	25.01%	26.73%
Public	7.80%	7.79%	8.03%	8.34%	9.63%	9.52%	9.27%	9.35%	9.37%	9.20%	9.21%	9.39%
Total Shareholders	97,043	89,955	79,216	82,151	91,334	97,258	1,27,897	1,28,725	1,29,002	1,26,599	1,26,776	1,29,077

Market Transactions

Unlock Premium Features

Analyst Target, Price, EPS and Revenue Projections

Projection

Unlock Premium Features

Get In-depth insights on EPS and Revenue forecasts

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q3 FY26

Investor Presentation

Q2 FY26

Investor Presentation

Q1 FY26

Investor Presentation

Q3 FY25

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

Investor Presentation

Q2 FY25

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

Investor Presentation

Q1 FY25

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

Investor Presentation

Q4 FY24

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

Investor Presentation

Q3 FY24

Showing 1 - 8 of 37

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Encumbrance Disclosure

1 hour ago

Promoter pledge/release disclosure for Emami by Diwakar & Suraj Finvest

On 16‑Feb‑2026 Diwakar Finvest Pvt Ltd and Suraj Finvest Pvt Ltd disclosed creation and release of pledges on Emami Ltd shares under Reg.31(1)/(2): Diwakar (holding 9,87,94,786 / 22.63%) had pledges with Bajaj Finance with post‑event encumbrance ~2.31 crore (5.30%); Suraj Finvest (holding 10,56,30,326 / 24.20%) created a pledge of 53.62 lakh (post‑encumbrance ~56.11 lakh, 1.29%) to IDBI Trusteeship/DBS.

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Frequently Asked Questions about Emami Ltd

Emami Ltd (EMAMILTD) is currently trading at 490.95 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Emami Limited is a leading FMCG company in India, specializing in personal care and healthcare products, with prominent brands like Navratna, BoroPlus, and Zandu in its portfolio. In Q3FY26, Emami achieved strong performance with consolidated net sales of ₹1,147 crore, growing by 11%, driven by a robust 9% volume growth in its domestic market and 9% growth in international business. The company showcased successful innovation and portfolio expansion, launching products such as Kesh King Gold and BoroPlus variants. This strategy aligned with their focus on premiumization and capturing evolving consumer needs. Emami's omnichannel approach has been effective, with organized channels contributing 32% of revenues. The company's digital strategy is advancing, with digital spending accounting for 50% of media expenses, enabling targeted consumer engagement. The company declared a dividend of ₹6 per share as the second interim dividend for FY26, illustrating Emami's confidence in its financial performance and commitment to rewarding shareholders.

Over the past 52 weeks, Emami Ltd has traded between a low of ₹470.00 and a high of ₹655.40. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Emami Ltd has a market capitalization of approximately 21,305.57. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Emami Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 26.61 and operates in the FMCG sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 21,305.57 Cr, Emami Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Emami Ltd operates in the FMCG sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Emami Ltd is 26.61. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The rules are being implemented in a phased manner, with major changes like the increase in contract size and reduction in weekly expiries starting from November 20, 2024.

The most significant positive is the government's major push for the Ayurveda sector, including setting up new institutes and upgrading labs. This directly benefits Emami's strong Ayurvedic portfolio, led by the Zandu brand, by enhancing credibility and market demand.

Emami Ltd

Stock Summary and Key Metrics

Investment Checklist

Investment Checklist

Overview

Financial Ratios

Technicals

Forecasts

Unlock Premium Features

Upgrade

Peers

Price Chart Comparison